Search Results - "Gilly, F. N."

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients by Passot, G, Bakrin, N, Roux, A.S, Vaudoyer, D, Gilly, F.-N, Glehen, O, Cotte, E

“…Abstract Introduction Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) have demonstrated promising results in the treatment of…”
Get full text

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry by Villeneuve, L, Passot, G, Glehen, O, Isaac, S, Bibeau, F, Rousset, P, Gilly, F N

“…Rare peritoneal cancers represent complex clinical situations requiring a specific and multidisciplinary management. Because of their rarity, lack of awareness…”
Get full text

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 Patients by Bakrin, N., Cotte, E., Golfier, F., Gilly, F. N., Freyer, G., Helm, W., Glehen, O., Bereder, J. M.

“…Background Epithelial ovarian carcinoma is the main cause of death from gynaecological cancers in the western world. The initial response rate to the frontline…”
Get full text

Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: Results of EVOCAPE 2 multicentre prospective study by Cotte, E, Peyrat, P, Piaton, E, Chapuis, F, Rivoire, M, Glehen, O, Arvieux, C, Mabrut, J.-Y, Chipponi, J, Gilly, F.-N

“…Abstract Aim In digestive cancers, the prognostic significance of intraperitoneal free cancer cells remains unclear (IPCC). The main objective of this study…”
Get full text

Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin by Glehen, O., Cotte, E., Schreiber, V., Sayag-Beaujard, A. C., Vignal, J., Gilly, F. N.

“…Background: Colorectal cancer with peritoneal carcinomatosis is usually considered incurable. The purpose of this study was to evaluate the efficacy of…”
Get full text

Surgery Combined With Peritonectomy Procedures and Intraperitoneal Chemohyperthermia in Abdominal Cancers With Peritoneal Carcinomatosis: A Phase II Study by GLEHEN, O, MITHIEUX, F, GILLY, F. N, OSINSKY, D, BEAUJARD, A. C, FREYER, G, GUERTSCH, Ph, FRANCOIS, Y, PEYRAT, P, PANTEIX, G, VIGNAL, J

“…To evaluate the tolerance of peritonectomy procedures (PP) combined with intraperitoneal chemohyperthermia (IPCH) in patients with peritoneal carcinomatosis…”
Get full text

Malignant Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is GLUT1 Expression a Major Prognostic Factor? A Preliminary Study by Hommell-Fontaine, J., Isaac, S., Passot, G., Decullier, E., Traverse-Glehen, A., Cotte, E., You, B., Mohamed, F., Gilly, F. N., Glehen, O., Berger, F.

“…Purpose Diffuse malignant peritoneal mesothelioma (DMPM) is a rare primary peritoneal malignancy. Its prognosis has been improved by an aggressive locoregional…”
Get full text

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study by Etienne-Grimaldi, M-C, Mahamat, A, Chazal, M, Laurent-Puig, P, Olschwang, S, Gaub, M-P, Formento, J-L, Formento, P, Sudaka, A, Boige, V, Abderrahim-Ferkoune, A, Benchimol, D, André, T, Houry, S, Faucheron, J-L, Letoublon, C, Gilly, F-N, Delpero, J-R, Lasser, P, Pradere, B, Pezet, D, Penault-Llorca, F, Milano, G

“…Background: To test the prognostic value of tumour protein and genetic markers in colorectal cancer (CRC) and examine whether deficient mismatch repair (dMMR)…”
Get full text

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer by Milano, G., Etienne-Grimaldi, M.-C., Dahan, L., Francoual, M., Spano, J.-P., Benchimol, D., Chazal, M., Letoublon, C., André, T., Gilly, F.-N., Delpero, J.-R., Formento, J.-L.

“…Background: In advanced colorectal cancer, K-Ras somatic mutations predict resistance to mAbs targeting epidermal growth factor receptor (EGFR). Relationships…”
Get full text

Intraperitoneal vascular endothelial growth factor burden in peritoneal surface malignancies treated with curative intent: The first step before intraperitoneal anti-vascular endothelial growth factor treatment? by Passot, G, Bakrin, N, Garnier, L, Roux, A, Vaudoyer, D, Wallet, F, Gilly, F.N, Glehen, O, Cotte, E

“…Abstract Introduction Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors in solid tumours and plays an important role in…”
Get full text

Frequent intragenic rearrangements of DPYD in colorectal tumours by van Kuilenburg, A B P, Etienne-Grimaldi, M-C, Mahamat, A, Meijer, J, Laurent-Puig, P, Olschwang, S, Gaub, M-P, Hennekam, R C M, Benchimol, D, Houry, S, Letoublon, C, Gilly, F-N, Pezet, D, Andre, T, Faucheron, J-L, Abderrahim-Ferkoune, A, Vijzelaar, R, Pradere, B, Milano, G

“…Dihydropyrimidine dehydrogenase is a crucial enzyme for the degradation of 5-fluorouracil (5FU). DPYD, which encodes dihydropyrimidine dehydrogenase, is prone…”
Get full text

Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study by Brigand, C, Monneuse, O, Mohamed, F, Sayag-Beaujard, A C, Isaac, S, Gilly, F N, Glehen, O

“…Peritoneal mesothelioma is a rare disease with few therapeutic options. Recently, the combination of cytoreductive surgery with intraperitoneal hyperthermic…”
Get full text

Outcome of ileal pouch after secondary diagnosis of Crohn's disease by PEYREGNE, V, FRANCOIS, Y, GILLY, F.-N, DESCOS, J.-L, FLOURIE, B, VIGNAL, J

“…Ileal-pouch anal anastomosis is sometimes performed inappropriately in Crohn's disease patients. The aim of this study was to evaluate long-term results in…”
Get full text

Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG‐RENAPE) by Passot, G., Dumont, F., Goéré, D., Arvieux, C., Rousset, P., Regimbeau, J.‐M., Elias, D., Villeneuve, L., Glehen, O., Abba, J., Abboud, K., Carere, S., Durand‐Fontanier, S., Eveno, C., Facy, O., Gelli, M., Gilly, F.‐N., Karoui, M., Lo Dico, R., Ortega‐Deballon, P., Pocard, M., Quenet, F., Rat, P., Sabbagh, C., Sgarbura, O., Thibaudeau, E., Vaudoyer, D., Wernert, R.

“…Background The peritoneal cancer index (PCI) is a comparative prognostic factor for colorectal peritoneal metastasis (CRPM). The ability of laparoscopy to…”
Get full text

MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis by Cotton, F., Pellet, O., Gilly, F.-N., Granier, A., Sournac, L., Glehen, O.

“…Peritonectomy procedures with intraperitoneal chemohyperthermia are an effective but costly treatment for peritoneal carcinomatosis (PC). Consequently a proper…”
Get full text

Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies by MONNEUSE, O, BEAUJARD, A. C, GUIBERT, B, GILLY, F. N, MULSANT, P, CARRY, P. Y, BENOIT, M, GLEHEN, O

“…There is no standard treatment for patients with pleural malignancies. The aim of this prospective study was to investigate the toxicity and long-term results…”
Get full text

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study by Kepenekian, V, Elias, D, Passot, G, Mery, E, Goere, D, Delroeux, D, Quenet, F, Ferron, G, Pezet, D, Guilloit, J M, Meeus, P, Pocard, M, Bereder, J M, Abboud, K, Arvieux, C, Brigand, C, Marchal, F, Classe, J M, Lorimier, G, De Chaisemartin, C, Guyon, F, Mariani, P, Ortega-Deballon, P, Isaac, S, Maurice, C, Gilly, F N, Glehen, O

“…Diffuse malignant peritoneal mesothelioma (DMPM) is a severe disease with mainly locoregional evolution. Cytoreductive surgery and hyperthermic intraperitoneal…”
Get full text

Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies by Passot, G, Bakrin, N, Isaac, S, Decullier, E, Gilly, F.N, Glehen, O, Cotte, E

“…Abstract Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered the only curative treatment for many…”
Get full text

Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures by Glehen, O, Osinsky, D, Cotte, E, Kwiatkowski, F, Freyer, G, Isaac, S, Trillet-Lenoir, V, Sayag-Beaujard, A C, François, Y, Vignal, J, Gilly, F N

“…Peritoneal carcinomatosis has been regarded as a lethal clinical entity. Recently, aggressive treatments combining intraperitoneal chemohyperthermia (IPCH)…”
Get full text

Peritoneal carcinomatosis from non-gynecologic malignancies : Results of the EVOCAPE 1 multicentric prospective study by SADEGHI, B, ARVIEUX, C, PORCHERON, J, PEIX, J. L, FRANCOIS, Y, VIGNAL, J, GILLY, F. N, GLEHEN, O, BEAUJARD, A. C, RIVOIRE, M, BAULIEUX, J, FONTAUMARD, E, BRACHET, A, CAILLOT, J. L, FAURE, J. L

“…Peritoneal carcinomatosis (PC) is a common evolution of digestive cancer, associated with a poor prognosis. Yet it is poorly documented in the literature…”
Get full text